Malnutrisyon ve Nutrisyonel Bozukluklarda Görülen Nörolojik ve Nöropsikiyatrik Bulgular
Özet
Malnütrisyon ve besin öğelerindeki dengesizlikler, nörotransmitter sentezini ve beyin fonksiyonlarını doğrudan etkileyerek depresyon, kognitif bozukluklar ve nörolojik hasarlar gibi ciddi nöropsikiyatrik sorunlara yol açabilmektedir. Özellikle B grubu vitaminleri, D vitamini, omega-3 yağ asitleri ve çeşitli minerallerin eksikliği, mental sağlık ve bilişsel gelişim üzerinde kalıcı olumsuz etkilere neden olmaktadır. Beslenme durumunun düzenlenmesi ve eksikliklerin giderilmesi, bu tür psikiyatrik ve nörolojik bozuklukların önlenmesi veya tedavisinde kritik bir rol oynamaktadır.
Malnutrition and imbalances in nutrient intake directly impact neurotransmitter synthesis and brain function, leading to serious neuropsychiatric conditions such as depression, cognitive impairment, and neurological damage. Deficiencies in essential nutrients, particularly B vitamins, vitamin D, omega-3 fatty acids, and various minerals, cause lasting negative effects on mental health and cognitive development. Addressing these nutritional deficiencies is critical for both the prevention and management of these psychiatric and neurological disorders.
Referanslar
Türk Çocuk Gastroenteroloji, Hepatoloji ve Beslenme Derneği, Çocuklarda Malnütrisyon Tanı ve Tedavi Rehberi, 2020.
Koloski NA, Jones M, Talley NJ. Evidence that independent gutto- brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study. Aliment Pharmacol Ther. 2016;44(6):592–600.
Lim SY, Kim EJ, Kim A, et al. Nutritional factors affecting mental health. Clin Nutr Res. 2016;5(3):143–52.
Hallahan B, Ryan T, Hibbeln JR, et al. Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression. Br J Psychiatry. 2016;209(3):192–201.
Türk Çocuk Gastroenteroloji, Hepatoloji ve Beslenme Derneği, Okul Çocuğu ve Ergen Beslenmesi Rehberi, 2020.
Messamore E, McNamara RK. Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: rationale and implementation. Lipids Health Dis. 2016;15:25.
Pottala J, Yaffe K, Robinson JG, et al. Omega-3 fatty acids linked to brain volume. Neurology. 22 Jan 2014.
Troisi A. Low cholesterol is a risk factor for attentional impulsivity in patients with mood symptoms. Psychiatry Res. 2011;188(1):83–7.
Smith AD, Smith SM, de Jager CA, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One. 2010;5(9):e12244.
McCormick LM, Buchanan JR, Onwuameze OE, et al. Beyond alcoholism: Wernicke-Korsakoff syndrome in patients with psychiatric disorders. Cogn Behav Neurol. 2011;24(4):209–16.
Scalzo SJ, Bowden SC, Ambrose ML, et al. Wernicke-Korsakoff syndrome not related to alcohol use: a systematic review. J Neurol Neurosurg Psychiatry. 2015;86(12):1362–8
Isenberg-Grzeda E, Alici Y, Hatzoglou V, et al. Nonalcoholic thiamine- related encephalopathy (Wernicke-Korsakoff syndrome) among inpatients with cancer: a series of 18 cases. Psychosomatics. 2016;57(1):71–81
Wijnia JW, Oudman E, Bresser EL, et al. Need for early diagnosis of mental and mobility changes in Wernicke encephalopathy. Cogn Behav Neurol. 2014;27(4):215–21.
Thomson AD, Guerrini I, Marshall EJ. The evolution and treatment of Korsakoff’s syndrome: out of sight, out of mind? Neuropsychol Rev. 2012;22(2):81–92.
Lonsdale D. Thiamine and magnesium: keys to disease. Med Hypotheses. 2015;84:129–34
Kowalska E, Kozik A. The genes and enzymes involved in the biosynthesis of thiamin and thiamin diphosphate in yeasts. Cell Mol Biol Lett. 2008;13(2):271–82.
Petrovski S, Shashi V, Petrou S, et al. Exome sequencing results in successful riboflavin treatment of a rapidly progressive neurological condition. Cold Spring Harb Mol Case Stud. 2015;1:257.
Wyllie R., Hyams J., Kay M. Pediatric Gastrointestinal and Liver Disease. 5th Edition. USA: 2017. p. 1071.
Kennedy DO. B vitamins and the brain: mechanisms, dose and efficacy- a review. Nutrients. 2016;8:68.
Skarupski KA, Tangney C, Li H, et al. Longitudinal association of vitamin B-6, folate, and vitamin B-12 with depressive symptoms among older adults over time. Amer J Clin Nutr. 2010;92(2): 269–70
Moorthy D, Peter I, Scott TM, et al. Status of vitamins B-12 and B-6 but not of folate, homocysteine, and the methylenetetrahydrofolate reductase C677T polymorphism are associated with impaired cognition and depression in adults. J Nutr. 2012;142(8):1554–60.
CDC. Second national report on biochemical indicators of diet and nutrition in the US population. Hyattsville: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2012.
Ramsey D. Vitamin deficiencies and mental health: how are they linked? Curr Psychiatr Ther. 2013;12(1):37–44.
Grober U, Kisters K, Schmidt J. Neuroenhancement with vitamin B12—Underestimated neurological significance. Nutrients. 2013;5(12):5031–45.
National Institutes of Health (NIH). Vitamin B12. https://ods. od.nih.gov/factsheets/VitaminB12-HealthProfessional/ updated 2/11/16.
Kinsman RA, Hood J. Some behavioral effects of ascorbic acid deficiency. Am J Clin Nutr. 1971;24:455–64.
Report of the dietary guidelines advisory committee on the dietary guidelines for Americans, 2010 section D2–23.
Andre R, Gabielli A, Laffitte E, Kherad O. Atypical scurvy associated with anorexia nervosa. Ann Dermatol Venereol. 2016;144(2):125–9.
Strumia R. Dermatologic signs in patients with eating disorders. Am J Clin Dermatol. 2005;6(3):165–73.
Puchalska P, Crawford PA. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab. 2017;25(2):262–84.
Ginsberg LD. L-methylfolate effective in the treatment of a MDD. APA 2010, Poster NR346. Psychiatric Dispatches: News from the 163rd Annual Meeting of the American Psychiatric Association. Primary Psychiatry. July 1, 2010.
http://www.mayoclinic.org/drugs-supplements/folate/safety/hrb-20059475.
Ransom J, Morgan PJ, McCaffery PJ, et al. The rhythm of retinoids in the brain. J Neurochem. 2014;129(3):366–76.
Bremner J. The neurobiology of retinoic acid in affective disorders. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008;32(2):315–31.
Alzoubi KH, OF Khabour, Hassan RE, et al. The effect of genetic polymorphisms of RARA gene on the adverse effects profile of isotretinoin-treated acne patients. Int J Clin Pharmacol Ther. 2013;51(8):631–40.
Nerhus M, Berg AO, Dahl SR, et al. Vitamin D status in psychotic disorder patients and healthy controls- The influence of ethnic background. Psychiatry Res. 2015;230(2):616-21.
Graham KA, Keefe RS, Lieberman JA, et al. Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with firstepisode schizophrenia. Early Interv Psychiatry. 2015;9:397–405.
Chiang M, Natarajan R, Fan X. Vitamin D in schizophrenia: a clinical review. Evid Based Ment Health. 2016;19(1):6–9.
Patrick RP, Ames B. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J. 2015;29(6):2207–22.
Wyllie R., Hyams J., Kay M. Pediatric Gastrointestinal and Liver Disease. 5th Edition. USA: 2017. p. 1072.
Walsh WJ. Nutrient power: heal your biochemistry and heal your brain. New York: Skyhorse Publishing; 2012. p. 18–20; 141.
Devkota BP. Magnesium. 2014. Medscape. Retrieved from: http://emedicine.medscape.com/article/2088140-overview#a2
Manganese. Micronutrient information Center. Linus Pauling Institute. Oregon State University. Reviewed in 2010 by Michael Aschner and Gray EB Stahlman. http://lpi.oregonstate.edu/mic/ minerals/manganese
National Institutes of Health (NIH). Selenium. Retrieved from: https://ods.od.nih.gov/factsheets/Selenium-HealthProfessional/
Nuttall KL. Evaluating selenium poisoning. Ann Clin Lab Sci. 2006;36(4):409–20.
Cope EC, Levenson CW. Role of zinc in the development and treatment of mood disorders. Curr Opin Clin Nutr Metab Care. 2010;13(6): 685–9.
